Medication-related osteonecrosis of the jaw (MRONJ), a severe side effect caused by
antiresorptive antiangiogenic medication, particularly bisphosphonates (BPs), has become a …

The mandible (lower jaw) bone is aesthetically responsible for sha** the lower face,
physiologically in charge of the masticatory movements, and phonetically accountable for …

(1) Background: Medication-related osteonecrosis of the jaws (MRONJ) is an adverse drug
reaction characterized by progressive bone disruption and necrosis in the mandibular …

Ethanol influenced microwave-assisted extraction was performed for obtaining of natural
antioxidants from spent filter coffee. The process included response surface methodology …

Medication-related osteonecrosis of the jaw (MRONJ) is a relatively new pathology that
involves the head and neck region. The first cases were described by Marx in 2003 (Marx …

Bone-modifying agents (BMAs) are integral to managing patients with advanced cancer.
They improve quality of survival by reducing skeletal-related events, treating …

Il trattamento di ONJ è, dalla sua comparsa in letteratura, argomento molto dibattuto, prima,
come osteonecrosi delle ossa mascellari (BRONJ) associata a bisfosfonati (BP) …

Objective This study evaluated the effectiveness of a submental island flap in closing
advanced mandibular medication‐related osteonecrosis of the jaw (MRONJ) wounds in …

Medication-related osteonecrosis of the jaw (MRONJ) is a growing problem without an
effective treatment, presenting as necrotic bone sections exposed via lesions in the …

Background and objectives: Although it is very uncommon, medication-induced
osteonecrosis of the jaw (also known as MRONJ) can have serious consequences …